TRAVERE THERAPEUTICS, INC. Disposal Group, Including Discontinued Operation, Assets, Current
TRAVERE THERAPEUTICS, INC. (TVTX) had Disposal Group, Including Discontinued Operation, Assets, Current of $0 as of 2023-12-31, per its 10-K filed 2024-02-20.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2024-02-20
- 2023-12-31: Disposal Group, Including Discontinued Operation, Assets, Current $0.00.
- 2023-09-30: Disposal Group, Including Discontinued Operation, Assets, Current $0.00.
- 2022-12-31: Disposal Group, Including Discontinued Operation, Assets, Current $2.99M.
| Period end | Disposal Group, Including Discontinued Operation, Assets, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-20 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 |
| 2022-12-31 | $2.99M 10-K · filed 2024-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |